Drug Metabolism and New Drug Development for Cancers—2nd Edition

Dear Colleagues,

We invite you to contribute to this Special Issue, "Drug Metabolism and New Drug Development for Cancers—2nd Edition", which follows the previous edition. Cancer is one of the top causes of death worldwide. However, medical sciences are working tirelessly to tackle this issue, with the primary goal being the development of new anticancer drugs and treatments. Understanding metabolic pathways and developing new molecules and formulations for drug delivery are but a few tools with which to climb this steep mountain. The path from developing an active ingredient to implementing the drug into clinical practice is long and involves the work of many specialists.

This Special Issue is devoted to “Drug Metabolism and New Drug Development for Cancers” and aims to publish original articles as well as interesting review articles on the following topics:

• The biochemistry of anticancer molecules;
• The impact of anticancer drugs/substances on metabolism;
• Natural compounds/extracts and plant screening for antineoplastic activity metabolites;
• Studies in pharmaceutical chemistry: drug structure–activity relationships or the development of new molecules;
• Developing new delivery methods for known substances, for example, formulating new nanoforms such as liposomes, micelles, nanospheres, etc.

Additionally, this Special Issue will provide a summary of important research in the development of medical sciences.

Prof. Dr. Anna Jelińska
Dr. Szymon Tomczak
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Metabolites is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.